BioAgilytix Closes Acquisition of Australia-based 360biolabs®

The Latest News from BioAgilytix

30 October, 2014

BioAgilytix Validates 20 New Oncology Biomarkers

BioAgilytix, a leading provider of contract bioanalytical services, has validated 20 key oncology biomarkers in an effort to expedite the search for a cure.  These validated assays will allow drug…

Read More

18 July, 2014

BioAgilytix Recognized For Quality Laboratory Services

BioAgilytix has met all criteria for Laboratory Accreditation by COLA, a national healthcare accreditation organization.  Accreditation is only given to laboratories that apply rigid standards of quality in day-to-day operations, demonstrate…

Read More

25 June, 2014

BioAgilytix Announces the Creation of an Advisory Board

BioAgilytix, a leading provider of contract bioanalytical testing services, today announced the formation of an Advisory Board with deep scientific, commercial and regulatory expertise in the Biotechnology, Pharmaceutical and Contract…

Read More

23 May, 2014

BioAgilytix Named 2014 CRO of the Year by the Triangle Business Journal

BioAgilytix is honored to be named the 2014 CRO of the Year by the Triangle Business Journal in their 2014 Life Sciences Awards!  This award recognizes BioAgilytix’s tremendous growth over…

Read More

22 April, 2014

BioAgilytix Welcomes Dr. Dominique Gouty as Vice President of Business Operations

BioAgilytix, a leading provider of contract bioanalytical testing services, today announced that Dominique Gouty has joined the company as Vice President of Business Operations, where she will hold key roles…

Read More

5 March, 2014

BioAgilytix Becomes the First CRO to Validate Meso Scale Discovery’s V-PLEX Human Cytokine 30-Plex Assay

Learn about the MSD platform here.BioAgilytix, a leading bioanalytical testing laboratory specializing in immunoassays and cell-based assays, has validated Meso Scale Discovery’s V-PLEX™ Human Cytokine 30-plex assay, making it the…

Read More

25 February, 2014

BioAgilytix Offers New Capabilities in Support of Biosimilar Development

BioAgilytix, a leading bioanalytical testing laboratory specializing in immunoassays and cell-based assays, announced today our support of development and release testing for biosimilar large molecule therapeutics.  “Our expanded capability and…

Read More

13 January, 2014

BioAgilytix Welcomes Kelley Intehar as Senior Director of Product Management

BioAgilytix, a leading provider of contract bioanalytical testing services, today announced that Kelley Intehar has joined the company as Senior Director of Product Management. Kelley is a seasoned science and…

Read More

10 December, 2013

BioAgilytix Names Jim Datin Chief Executive Officer

BioAgilytix, a leading provider of contract bioanalytical testing services, today announced that Jim Datin has joined the company as Chief Executive Officer. Jim is a seasoned executive with significant experience…

Read More